1. 1172. Mucormycosis Treated with Isavuconazole: A matched-Pair Analysis from the FungiScope® Registry. (31st December 2020) Authors: Seidel, Danila; Cornely, Oliver; Vehreschild, Maria J G T; Koehler, Philipp; Salmanton-García, Jon; Klimko, Nikolay; Herbrecht, Raoul; Heinemann, Melina; Prattes, Jürgen; Schalk, Enrico; Miceli, Marisa H; Ráčil, Zdeněk; Falces-Romero, Iker; Hoenigl, Martin; Kessel, Johanna; Bertz, Hartmut; Novak,... Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S611 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1210A Phase 3, Randomized, Double-Blind, Non-inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole versus Voriconazole in Patients with Invasive Mold Disease (SECURE): Outcomes in Neutropenic Patients. (December 2014) Authors: Patterson, Thomas; Selleslag, Dominik; Mullane, Kathleen; Cornely, Oliver; Hope, William; Lortholary, Olivier; Zeiher, Bernhardt; Maher, Rochelle; Lee, Misun; Huang, Wenmei; Kontoyiannis, Dimitrios Journal: Open forum infectious diseases Issue: Volume 1(2014)Supplement 1 Page Start: S36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 123. Oral Ibrexafungerp Outcomes by Fungal Disease in Patients from an Interim Analysis of a Phase 3 Open-label Study (FURI). (4th December 2021) Authors: Pappas, Peter G; Cornely, Oliver; Koehler, Philipp; McCarty, Todd P; Alexander, Barbara D; Miller, Rachel; Vazquez, Jose A; Sanders, John W; Morse, Caryn; Ostrosky-Zeichner, Luis; Krause, Robert; Prattes, Jürgen; Spec, Andrej; Rautemaa-Richardson, Riina; Bazaz, Rohit; Walsh, Thomas J; Marty, Fran... Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1248. Efficacy and Safety of Oral Ibrexafungerp in 41 Patients with Refractory Fungal Diseases, Interim Analysis of a Phase 3 Open-label Study (FURI). (31st December 2020) Authors: Alexander, Barbara D; Cornely, Oliver; Pappas, Peter; Miller, Rachel; Vazquez, Jose A; Ostrosky-Zeichner, Luis; Spec, Andrej; Rautemaa-Richardson, Riina; Krause, Robert; Thompson III, George R; Morse, Caryn; Sanders, John W; Andes, David; Andes, David; Lyon, George; Marty, Francisco M; Silverman,... Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 1598. Clinical implications of azole-resistant vs. azole-susceptible invasive aspergillosis in hematological malignancy (CLARITY) – a multicenter study. (31st December 2020) Authors: Seidel, Danila; Cornely, Oliver; Zarrouk, Marouan; Koehler, Philipp; Meis, Jacques F; Salmanton-García, Jon; Vehreschild, Jörg Janne; Christner, Martin; Gräfe, Stefanie K; Falces-Romero, Iker; Lagrou, Katrien; Maertens, Johan; Reséndiz- Sharpe, Agustín; Racil, Zdenek; Weinbergerová, Barbora; Vale... Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S795 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 372. Attributable Mortality of Candidemia After Introduction of Echinocandins. (26th November 2018) Authors: Cornely, Florian; Cornely, Oliver; Koehler, Philipp; Koehler, Felix; Mellinghoff, Sibylle Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 412. Clinical and Pharmacoeconomic Evaluation of Antifungal Prophylaxis With Continuous Micafungin Compared to Posaconazole With Micafungin Bridging in Patients Undergoing Allogeneic Stem Cell Transplantation: A 6-Year Cohort Analysis. (26th November 2018) Authors: Heimann, Sebastian M; Vehreschild, Maria J G T; Franke, Bernd; Cornely, Oliver; Hamprecht, Axel; Piepenbrock, Ellen; Scheid, Christoph; Vehreschild, Janne Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 983. Outcomes of Candida Bone and Joint Infections in Eight Patients from a Phase 3 Open-label Study (FURI). (4th December 2021) Authors: Sanders, John W; Morse, Caryn; Cornely, Oliver; Koehler, Philipp; Krause, Robert; Prattes, Jürgen; Weiss, Guenter; Azie, Nkechi; Angulo, David A Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S583 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 992. Oral Ibrexafungerp Outcomes in Patients with Oropharyngeal and Esophageal Candidiasis from an Interim Analysis of a Phase 3 Open-label Study (FURI). (4th December 2021) Authors: Vazquez, Jose A; Cornely, Oliver; Koehler, Philipp; Rautemaa-Richardson, Riina; Bazaz, Rohit; Marshall Lyon, G; Marty, Francisco M; Gonzalez-Bocco, Isabel H; Miller, Rachel; Walsh, Thomas J; Pappas, Peter; McCarty, Todd P; Sanders, John W; Morse, Caryn; Ostrosky-Zeichner, Luis; Krause, Robert; Pr... Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S586 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Clinical Outcomes of Serious Infections due to Carbapenem-Resistant Enterobacteriaceae (CRE) in TANGO II, a Phase 3, Randomized, Multi-National, Open-Label Trial of Meropenem-Vaborbactam (M-V) Vs. Best Available Therapy (BAT). (4th October 2017) Authors: Kaye, Keith S; Vazquez, Jose; Mathers, Amy; Daikos, George; Alexander, Elizabeth; Loutit, Jeffrey S; Zhang, Shu; Dudley, Michael N; Cornely, Oliver Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S534 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗